TheraCell, Inc. — Form D
TheraCell, Inc. of NORTHRIDGE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2010-10-01. The offering totals $3.0M, of which $1.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2010-10-01
- Form: D
- Accession: 0001502547-10-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $3.0M
- Amount sold: $1.3M
- Remaining: $1.7M
- Minimum investment: $10K
- Investors: 25
- Date of first sale: 2009-09-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-148431
Issuer
- Name: TheraCell, Inc.
- CIK: 0001502547
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 19355 BUSINESS CENTER DRIVE, NORTHRIDGE, CA, 91324
- Phone: 818-645-4081
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Danny M Gazit | Director | Northridge, CA |
| Richard K Grant | Director | Northridge, CA |
| Jan S Iwanczyk | Director | Northridge, CA |
| Joseph M Miller | Director | Northridge, CA |
| Bradley E Patt | Director | Sherman Oaks, CA |
| Frank M Phillips | Director | Northridge, CA |
| Richard K Grant | Executive Officer | Northridge, CA |
| Joseph Miller | Director | Madison, WI |
| Frank Phillips | Director | Chicago, IL |
| Andrew Carter | Executive Officer | Syracuse, NY |
| Bradley Patt | Director | Sherman Oaks, CA |
| Bradley Patt | Executive Officer | Sherman Oaks, CA |
| Jan Iwanczyk | Director | Sherman Oaks, CA |
| Nelson Scarborough | Executive Officer | Northridge, CA |
Other filings by this issuer (1)
More